Legal & General Group PLC Compugen LTD Transaction History

Legal & General Group PLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.68 - $1.11 $5,478 - $8,942	-8,056 Reduced 22.16%	28,302 $19,000
Q2 2022 Aug 22, 2022	SELL	$1.57 - $3.33 $35,510 - $75,317	-22,618 Reduced 38.35%	36,358 $64,000
Q1 2022 May 16, 2022	BUY	$2.76 - $4.64 $50,875 - $85,529	18,433 Added 45.47%	58,976 $196,000
Q4 2021 Feb 14, 2022	SELL	$4.09 - $7.16 $22,167 - $38,807	-5,420 Reduced 11.79%	40,543 $174,000
Q2 2021 Aug 12, 2021	SELL	$6.87 - $9.16 $3,586 - $4,781	-522 Reduced 1.12%	45,963 $378,000
Q1 2021 May 17, 2021	BUY	$7.67 - $13.77 $275,782 - $495,114	35,956 Added 341.49%	46,485 $380,000
Q4 2020 Feb 12, 2021	BUY	$12.07 - $17.95 $65,419 - $97,289	5,420 Added 106.09%	10,529 $128,000
Q2 2020 Aug 14, 2020	BUY	$6.97 - $17.12 $35,609 - $87,466	5,109 New	5,109 $77,000

13.3M

191K

135K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $142M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.